Sun Radiopharma (formerly Pharmalucence)
Come see us at Booth 101!
Sun Radiopharma (formerly Pharmalucence), a Sun Pharma company, is a New England based parenteral drug manufacturer specializing in aseptic liquid and lyophilized fill and finish for Nuclear Medicine. We are a fully integrated pharmaceutical manufacturing facility performing comprehensive manufacturing services such as product and process development, analytical method development, commercial scale parenteral fill and finish, quality control, and release and stability testing.
Our 70,000 square foot manufacturing facility in Billerica Massachusetts is the region’s first drug production facility to utilize automated isolator technology in support of a wide array of needs, providing state of the art compliance capabilities for full commercial scale production for markets worldwide.
We currently manufacture 6 radiopharmaceuticals to service the Nuclear Medicine industry and are gearing up to manufacture other Sun Pharma injectable products as we develop into their U.S. parenteral manufacturing base of operations.
Founded in 2007, Pharmalucence was acquired by Sun Pharma in July of 2014. Please be sure to come visit us at Booth 101 to learn more about our products and company.
Brands: Sestamibi, Mebrofenin, Pyrophosphate, Sulfur Colloid, MDP and now Mertiatide.